glofitamab
roche
['1659', 'glofitamab', 'lymsm']
come and see the poster 1659 of the cd28/cd19 bispecific aiming to co-stimulate the effects of #glofitamab #bispecifics #lymsm #ash22
Clinical haematologist at Peter MacCallum Cancer Centre in Melbourne. Aggressive Lymphoma Lead. MDS/AML/myeloma.Early phase trials. Views are my own.